Delivery Order SPE2DB24D1205-SPE2DB25FCSZG

Award Date 1/13/25
Potential Completion Date 2/4/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,484.30, is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a completion date of November 25, 2024. The contract is a firm fixed-price agreement, and there is no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $12,740.00 and a completion date of February 4, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and this contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that the...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $6,765.08, is for the provision of BRUKINSA 80 MG CAPSULE 120S, a specialty pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of BRUKINSA 80 MG CAPSULE 120S, a specialty pharmaceutical product. The contract has a ceiling value of $7,242.15 and a completion date of October 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the prescription drug BRUKINSA 80 MG CAPSULE 120S. The contract has a ceiling value of $7,242.15 and an ultimate completion date of August 23, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor on this award. This contract is likely part of a...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $21,726.45 firm-fixed-price contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. The award has an ultimate completion date of September 6, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,242.15, is for the delivery of 4,566,339,517 units of the oncology medication BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of November 27, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $7,492.44, is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, valued at $6,765.08. The contract has an ultimate completion date of August 11, 2023 and is a Firm Fixed Price contract. This appears to be a task order issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $7,242.15, is for the delivery of the pharmaceutical product BRUKINSA 80 MG CAPSULE 120S. The contract has a performance period through July 31, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC)...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSZG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,370.00, is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed-price pricing type and a completion date of February 4, 2025. The contract was not set aside for any specific business category.

Generated 4/14/25, 10:29 AM